Trials / Unknown
UnknownNCT03252548
Pediatric Primary Immunodeficiency Disease (PID) in China
Clinical Characteristics and Prognosis of Primary Immunodeficiency Disease (PID) in Chinese Children
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Beijing Children's Hospital · Academic / Other
- Sex
- All
- Age
- 1 Day – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective cohort study of children diagnosed with primary immunodeficiency disease (PID). The aim is to investigate the clinical characteristics and prognosis of PID in Chinese children.
Detailed description
Primary immunodeficiency disease (PID) is a group of rare and fatal disease. However, the research about clinical characteristics, treatment, management and prognosis of Chinese children with PID is still not perfect and there is no basic and large database. Therefore, this study is conducted, in order to set up a complete database and long term follow up of Chinese children with PID, and establish foundations for basic research and precise medicine. This study is divided into two parts. In part one, pediatric patients with PID in the past 10 years will be collected retrospectively by review medical records from these centers, and investigate the clinical features and prognosis. In part two, all new cases with suspected PID will be collected. Clinical symptoms, physical examination, blood tests, and humoral and cellular immune functions will be detected. Gene tests would be done when necessary to confirm the diagnosis. Then follow up at 6-moth, 1-year, 2-year, 3-year, 4-year and 5-year respectively. The trial will be completed in 60 months.
Conditions
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2022-08-01
- Completion
- 2022-08-01
- First posted
- 2017-08-17
- Last updated
- 2018-01-03
Source: ClinicalTrials.gov record NCT03252548. Inclusion in this directory is not an endorsement.